Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells. 2009

Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL-32307, USA.

BACKGROUND Breast cancer is the second leading cause of cancer deaths in US women. We evaluated two novel compounds, piperidinyl-diethylstilbestrol (DES) and pyrrolidinyl-diethylstilbestrol (DES) for cytotoxicity against brine shrimp larvae, MCF-7 and rat normal liver cells. METHODS In vivo cytotoxicity was evaluated against shrimp larvae for 24 h, while in vitro cell toxicity was evaluated by dye binding crystal-violet method after 48 h. The role of these compounds on different phases of the cell cycle was assessed by flow cytometry. RESULTS In shrimp assay, piperidinyl-DES and pyrrolidinyl-DES were potent with 50% effective dose (ED(50)) values of 7.9+/-0.38 and 15.6+/-1.3 microM, respectively. In MCF-7 and normal liver cells, the 50% lethal concentration (LC(50)) values were 19.7+/-0.95, 17.6+/-0.4 microM and 35.1 and >50 microM, respectively. Cell cycle analyses indicated that MCF-7 cells were arrested at the G(0)/G(1) stage with these compounds. CONCLUSIONS The results indicate that pyrrolidinyl-DES possesses highly selective, potent anticancer activity.

UI MeSH Term Description Entries
D007814 Larva Wormlike or grublike stage, following the egg in the life cycle of insects, worms, and other metamorphosing animals. Maggots,Tadpoles,Larvae,Maggot,Tadpole
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D010880 Piperidines A family of hexahydropyridines.
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
January 2011, Canadian journal of physiology and pharmacology,
Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
October 1993, The Journal of steroid biochemistry and molecular biology,
Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
September 2017, Bioorganic & medicinal chemistry letters,
Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
May 2022, Medical oncology (Northwood, London, England),
Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
August 1998, Cancer letters,
Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
January 2014, Journal of cancer science & therapy,
Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
August 1983, Cancer research,
Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
December 1997, The Journal of endocrinology,
Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
November 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Ramesh B Badisa, and Selina F Darling-Reed, and Patrick Joseph, and John S Cooperwood, and Lekan M Latinwo, and Carl B Goodman
January 1982, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!